CSIMarket
 


Mylan N v   (MYL)
Other Ticker:  
 
 

MYL's EPS from Cont. Operations Growth by Quarter and Year

Mylan N V 's EPS from Cont. Operations results by quarter and year




MYL EPS from Cont. Operations (in $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 0.01 0.10 1.21
III Quarter September 0.36 0.37 0.34 0.17
II Quarter June 0.08 - 0.07 0.12
I Quarter March 0.04 - 0.17 0.78
FY   0.48 0.38 0.68 2.28



MYL EPS from Cont. Operations third quarter 2020 Y/Y Growth Comment
Mylan N V reported decrease in EPS from Cont. Operations in the third quarter by -2.7% to $ 0.36 , from the same quarter in 2019.
The decrease in the third quarter Mylan N V 's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations jump of 80.2%.

Looking into third quarter results within Major Pharmaceutical Preparations industry 22 other companies have achieved higher EPS from Cont. Operations growth. While Mylan N V ' s EPS from Cont. Operations decline of -2.7% ranks overall at the positon no. 1161 in the third quarter.




MYL EPS from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -90 % -91.74 % -
III Quarter September -2.7 % 8.82 % 100 % -48.48 %
II Quarter June - - -41.67 % 300 %
I Quarter March - - -78.21 % 95 %
FY   - -44.12 % -70.18 % 330.19 %

Financial Statements
Mylan N V 's third quarter 2020 EPS from Cont. Operations $ 0.36 MYL's Income Statement
Mylan N V 's third quarter 2019 EPS from Cont. Operations $ 0.37 Quarterly MYL's Income Statement
New: More MYL's historic EPS from Cont. Operations Growth >>


MYL EPS from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - -97.3 % -70.59 % 611.76 %
III Quarter September 350 % - 385.71 % 41.67 %
II Quarter June 100 % - -58.82 % -84.62 %
I Quarter March 300 % - -85.95 % -
FY (Year on Year)   - -44.12 % -70.18 % 330.19 %




EPS from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #23
Healthcare Sector #89
Overall #1161

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
2900 % 80.2 % -100 %
(Dec 31 2011)   (Jun 30 2019)
EPS from Cont. Operations third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #23
Healthcare Sector #89
Overall #1161
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
2900 % 80.2 % -100 %
(Dec 31 2011)   (Jun 30 2019)

EPS from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Mylan N V 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
2300 % 136.15 % -100 %
(March 31 2011)   (Mar 31 2019)


MYL's III. Quarter Q/Q EPS from Cont. Operations Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential EPS from Cont. Operations doubling of 350%, to $ 0.36 , from $0.08 in the second quarter.
Mylan N V is impressively improving, with recording better then normal gain, and additionally accelerating speed.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Mylan N V 's EPS from Cont. Operations growth quarter on quarter, overall rank is 124.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #13
Overall #124
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #13
Overall #124
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
2300 % 136.15 % -100 %
(March 31 2011)   (Mar 31 2019)


MYL's III. Quarter Q/Q EPS from Cont. Operations Comment
Mylan N v achieved in the III. Quarter 2020 above company average sequential EPS from Cont. Operations doubling of 350%, to $ 0.36 , from $0.08 in the second quarter.
MYL is going from strength to strength, not only reporting above regular increase, but also improving rate, Leslie F. Walker, market researcher from Toronto mentioned.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Mylan N V 's EPS from Cont. Operations growth quarter on quarter, overall rank is 124.


Mylan N V 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.49 $ 0.50 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) -1.99 % - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 763 # 1153 # 0 # 0 # 0




Cumulative EPS from Cont. Operations growth Comment


Mylan N v achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
192 %
10.43 %
-81.18 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
356.25 %
42.12 %
-71.67 %
(Sep. 30, 2010)   (Mar 31 2019)


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 57
S&P 500 # 763
Cumulative EPS from Cont. Operations growth Comment


Mylan N v achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
192 %
10.43 %
-81.18 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
356.25 %
42.12 %
-71.67 %
(Sep. 30, 2010)   (Mar 31 2019)


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 17
Sector # 57
S&P 500 # 763




Other EPS from Cont. Operations Growth
Major Pharmaceutical Preparations Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
MYL's EPS from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for MYL's Competitors
EPS from Cont. Operations Growth for Mylan N V 's Suppliers
EPS from Cont. Operations Growth for MYL's Customers

You may also want to know
MYL's Annual Growth Rates MYL's Profitability Ratios MYL's Asset Turnover Ratio MYL's Dividend Growth
MYL's Roe MYL's Valuation Ratios MYL's Financial Strength Ratios MYL's Dividend Payout Ratio
MYL's Roa MYL's Inventory Turnover Ratio MYL's Growth Rates MYL's Dividend Comparisons



Companies with similar EPS from Cont. Operations doubling for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2020
Masimo Corp-2.17%$ -2.174 
Orgenesis Inc -2.27%$ -2.273 
Mylan N v -2.70%$ -2.703 
Baxter International Inc -2.78%$ -2.778 
Eli Lilly And Company-2.92%$ -2.920 
Conmed Corporation-4.00%$ -4.000 
U S Physical Therapy Inc-7.58%$ -7.576 
Tactile Systems Technology Inc -7.69%$ -7.692 
Icu Medical Inc-7.75%$ -7.752 
Emergent Biosolutions Inc -10.71%$ -10.714 
Viemed Healthcare Inc -12.50%$ -12.500 
Bruker Corporation-12.50%$ -12.500 
Acadia Healthcare Company Inc -14.29%$ -14.286 
China Health Industries Holdings Inc -14.78%$ -14.783 
Biospecifics Technologies Corp-15.12%$ -15.116 
Biotelemetry Inc -16.67%$ -16.667 
Becton Dickinson And Company-16.98%$ -16.981 
Corcept Therapeutics Inc-17.39%$ -17.391 
Utah Medical Products Inc-19.00%$ -19.000 
Encompass Health Corporation-21.21%$ -21.212 
Intuitive Surgical Inc -22.09%$ -22.093 
Illumina Inc -23.27%$ -23.270 
Atrion Corporation-23.40%$ -23.404 
Cyanotech Corp-25.00%$ -25.000 
Innoviva inc -28.21%$ -28.205 
Zynex Inc-33.33%$ -33.333 
National Healthcare Corp-33.86%$ -33.858 
Msa Safety Inc-33.94%$ -33.945 
Dentsply Sirona Inc -34.21%$ -34.211 
Semler Scientific inc -38.33%$ -38.333 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

THFF's Profile

Stock Price

THFF's Financials

Business Description

Fundamentals

Charts & Quotes

THFF's News

Suppliers

THFF's Competitors

Customers & Markets

Economic Indicators

THFF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071